CHU Besancon Hopital Jean Minjoz

Besançon 25030

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cutaneous Squamous Cell Carcinoma, Crohn Disease, Crohn's Disease, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma, Microsatellite Instability-High (MSI-H), Non-Small Cell Lung Cancer (NSCLC), Non-melanoma Skin Cancer (NMSC), Renal Cell Carcinoma (RCC)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) — Running, not enrolling
• Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer — Running, not enrolling
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling